Peter Feinberg - 20 Sep 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
20 Sep 2021
Transactions value $
$116,114
Form type
4
Filing time
21 Sep 2021, 17:53:46
Previous filing
15 Sep 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $116K +4.75K +1361.03% $24.45 5.1K 20 Sep 2021 Direct F1
holding IMRX Class A Common Stock 392K 20 Sep 2021 General Partner of PF Associates L.P.
holding IMRX Class A Common Stock 477K 20 Sep 2021 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115K 20 Sep 2021 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.75 to $24.75. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.